메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kim Seyoung (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, Korea.) Kim Jeong Ah (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Korea.) Park Hyesook (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Preventive Medicine, College of Medicine, Graduate Program in System Health Science and Engineering, Ewha Womans Universit) Park Sohee (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Health Informatics and Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, Korea.) Oh Sanghoon (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Psychiatry, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea.) Jung Seung Eun (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Radiology, Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea.) Shin Hyoung-Shik (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Infectious Diseases, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.) Lee Jong Koo (COVID-19 Vaccine Safety Research Center, Seoul, Korea.National Cancer Center, Goyang, Korea.) Han Hee Chul (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Physiology, College of Medicine and Neuroscience Research Institute, Korea University, Seoul, Korea.) Woo Jun Hee (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Medicine Korea Tourism College Eldercare Center, Icheon, Korea.) Park Byung-Joo (COVID-19 Vaccine Safety Research Center, Seoul, Korea.National Academy of Medicine of Korea, Seoul, Korea.) Choi Nam-Kyong (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Korea.) Kim Dong-Hyun (COVID-19 Vaccine Safety Research Center, Seoul, Korea.Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, Korea.)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.39 No.26
발행연도
2024.7
수록면
1 - 11 (11page)
DOI
10.3346/jkms.2024.39.e220

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
During the coronavirus disease 2019 (COVID-19) pandemic, conclusively evaluating possible associations between COVID-19 vaccines and potential adverse events was of critical importance. The National Academy of Medicine of Korea established the COVID-19 Vaccine Safety Research Center (CoVaSC) with support from the Korea Disease Control and Prevention Agency to investigate the scientific relationship between COVID-19 vaccines and suspected adverse events. Although determining whether the COVID-19 vaccine was responsible for any suspected adverse event necessitated a systematic approach, traditional causal inference theories, such as Hill's criteria, encountered certain limitations and criticisms. To facilitate a systematic and evidence-based evaluation, the United States Institute of Medicine, at the request of the Centers for Disease Control and Prevention, offered a detailed causality assessment framework in 2012, which was updated in the recent report by the National Academies of Sciences, Engineering, and Medicine (NASEM) in 2024. This framework, based on a weight-of-evidence approach, allows the independent evaluation of both epidemiological and mechanistic evidence, culminating in a comprehensive conclusion about causality. Epidemiological evidence derived from population studies is categorized into four levels—high, moderate, limited, or insufficient—while mechanistic evidence, primarily from biological and clinical studies in animals and individuals, is classified as strong, intermediate, weak, or lacking. The committee then synthesizes these two types of evidence to draw a conclusion about the causal relationship, which can be described as “convincingly supports” (“evidence established” in the 2024 NASEM report), “favors acceptance,” “favors rejection,” or “inadequate to accept or reject.” The CoVaSC has established an independent committee to conduct causality assessments using the weightof-evidence framework, specifically for evaluating the causality of adverse events associated with COVID-19 vaccines. The aim of this study is to provide an overview of the weight-ofevidence framework and to detail the considerations involved in its practical application in the CoVaSC.
#Causality #COVID-19 Vaccines #Adverse Events #National Academy of Medicine of Korea #COVID-19 Vaccine Safety Research Center

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청
참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0